Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions

NCT06257420 is registered in ClinicalTrials.gov with Simmaron Research Inc. as lead sponsor.

NCT NCT06257420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06257420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions
Lead sponsor
Simmaron Research Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 11, 2023
Completion date
July 1, 2027
Enrollment
150 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

long-covid, myalgic encephalomyelitis